UBS Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $963K | Buy |
|
|||||
|
2025
Q1 | $211K | Sell |
|
|||||
|
2024
Q4 | $1.13M | Buy |
|
|||||
|
2024
Q3 | $186K | Buy |
|
|||||
|
2024
Q2 | $180K | Sell |
|
|||||
|
2024
Q1 | $476K | Buy |
|
|||||
|
2023
Q4 | $348K | Buy |
|
|||||
|
2023
Q3 | $175K | Sell |
|
|||||
|
2023
Q2 | $606K | Buy |
|
|||||
|
2023
Q1 | $573K | Sell |
|
|||||
|
2022
Q4 | $737K | Buy |
|
|||||
|
2022
Q3 | $137K | Buy |
|
|||||
|
2022
Q2 | $110K | Sell |
|
|||||
|
2022
Q1 | $732K | Sell |
|
|||||
|
2021
Q4 | $1.07M | Buy |
|
|||||
|
2021
Q3 | $870K | Buy |
|
|||||
|
2021
Q2 | $438K | Sell |
|
|||||
|
2021
Q1 | $798K | Buy |
|
|||||
|
2020
Q4 | $45K | Sell |
|
|||||
|
2020
Q3 | $75K | Buy |
|
|||||
|
2020
Q2 | $44K | Sell |
|
|||||
|
2020
Q1 | $200K | Buy |
|
|||||
|
2019
Q4 | $195K | Sell |
|
|||||
|
2019
Q3 | $2.05M | Buy |
|
|||||
|
2019
Q2 | $747K | Sell |
|
|||||
|
2019
Q1 | $3.3M | Buy |
|
|||||
|
2018
Q4 | $2.4M | Buy |
|
|||||
|
2018
Q3 | $2.65M | Buy |
|
|||||
|
2018
Q2 | $1.67M | Buy |
|
|||||
|
2018
Q1 | $154K | Sell |
|
|||||
|
2017
Q4 | $256K | Buy |
|
|||||
|
2017
Q3 | $148K | Buy |
|
|||||
|
2017
Q2 | $89K | Buy |
|
|||||
|
2017
Q1 | $75K | Sell |
|
|||||
|
2016
Q4 | $145K | Sell |
|
|||||
|
2016
Q3 | $142K | Buy |
|
|||||
|
2016
Q2 | $109K | Sell |
|
|||||
|
2016
Q1 | $744K | Buy |
|
|||||
|
2015
Q4 | $63K | Sell |
|
|||||
|
2015
Q3 | $82K | Buy |
|
|||||
|
2015
Q2 | $70K | Sell |
|
|||||
|
2015
Q1 | $609K | Sell |
|
|||||
|
2014
Q4 | $984K | Buy |
|